EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Mechanisms of resistance to bruton’s tyrosine kinase inhibitors: synergistic effects of tumor microenvironment regulation and signaling pathways

Xinyu Dong, Shujun Tang, Miaohong Chen, Qiuni Chen, Yifan Wang, Yuye Shi, Yuan Deng, Yue Chen, Zhengmei He, Liang Yu, Chunling Wang

Annals of Hematology · 2026

DOI: 10.1007/s00277-026-06775-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Hematology, 2026. Verfasst von Xinyu Dong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The Affiliated Huaian Clinical College of Xuzhou Medical University, Huai'an, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Drug Resistance, Neoplasm, Agammaglobulinaemia Tyrosine Kinase, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

It is widely acknowledged that B-cell lymphoma represent a significant threat to human health, and Bruton Tyrosine Kinase inhibitors (BTKi) have been shown to exhibit superior clinical efficacy and safety in comparison to conventional chemotherapy and immunotherapy modalities. However, as patients continue to use BTKi over a time, they will inevitably encounter the drug resistance. This resistance renders the therapeutic efficacy of BTKi, thereby significantly constraining its clinical benefits. Drug resistance of tumor is a multifaceted process influenced by numerous factors, mainly including individual genetic variations, tumor stem cells, drug inactivation, reduced drug absorption, and altered metabolism of anti-tumor drugs. The tumor microenvironment (TME) has been demonstrated to exert an important influence on the process of therapy resistance. It is evident that non-cellular components (e.g. the extracellular matrix, hypoxia, an acidified microenvironment, exosome, and cytokines) modulate the drug resistance through different mechanisms. These mechanisms include physical barriers that impede drug delivery, the formation of an immunosuppressive microenvironment, metabolic reprogramming and the activation of bypass signal moueculars. Furthermore, the presence of mutations of moleculars involved in the BCR signaling pathways (e.g. BTK and PLCG2 mutations) and the aberrant activation of key pathways such as PI3K-AKT-mTOR, NF-κB, Wnt/β-catenin and MAPK/ERK signaling further weakened the efficacy of BTKi. This review focus on the mechanism of BTKi resistance, the role of the TME and its components in drug resistance. It emphasized that targeting TME remodeling and combined the inhibition of multiple pathways may provide a new strategy for overcoming drug resistance, optimizing the treatment paradigm of B-cell lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentDrug Resistance, NeoplasmAgammaglobulinaemia Tyrosine KinaseSignal TransductionProtein Kinase InhibitorsLymphoma, B-CellAntineoplastic AgentsHumansAnimals

Stichwörter der Autor:innen

B-cell lymphomaBKTiDrug resistanceTumor microenvironment (TME)

Substanzen

Agammaglobulinaemia Tyrosine KinaseProtein Kinase InhibitorsBTK protein, humanAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Hematology, The Affiliated Huaian Clinical College of Xuzhou Medical University, Huai'an, China.
  • Northern Jiangsu Institute of Clinical Medicine, Nanjing Medical University, Nanjing, China.
  • Huaian Key Laboratory of Autoimmune Diseases, Huai'an, China.
  • Department of Hematology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China.
  • Department of Hematology, The Affiliated Huaian Clinical College of Xuzhou Medical University, Huai'an, China. yuliangha@163.com.
  • Department of Hematology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, China. yuliangha@163.com.

Zitieren

APA

Dong, X., Tang, S., Chen, M., Chen, Q., Wang, Y., Shi, Y., Deng, Y., Chen, Y., He, Z., Yu, L., & Wang, C. (2026). Mechanisms of resistance to bruton’s tyrosine kinase inhibitors: synergistic effects of tumor microenvironment regulation and signaling pathways. Annals of Hematology. https://doi.org/10.1007/s00277-026-06775-x

Vancouver

Dong X, Tang S, Chen M, Chen Q, Wang Y, Shi Y, et al. Mechanisms of resistance to bruton’s tyrosine kinase inhibitors: synergistic effects of tumor microenvironment regulation and signaling pathways. Annals of Hematology. 2026. doi:10.1007/s00277-026-06775-x

BibTeX
@article{Dong2026,
  author = {Dong, Xinyu and Tang, Shujun and Chen, Miaohong and Chen, Qiuni and Wang, Yifan and Shi, Yuye and Deng, Yuan and Chen, Yue and He, Zhengmei and Yu, Liang and Wang, Chunling},
  title = {Mechanisms of resistance to bruton’s tyrosine kinase inhibitors: synergistic effects of tumor microenvironment regulation and signaling pathways},
  journal = {Annals of Hematology},
  year = {2026},
  doi = {10.1007/s00277-026-06775-x}
}
Kostenlos starten →